Progress in the development of immunotherapy for the treatment of patients with cancer

S. A. Rosenberg

Research output: Contribution to journalArticle

Abstract

Several recent developments have hallmarked progress in tumour immunology and immunotherapy. The use of interleukin-2 (IL-2) in cancer patients demonstrated that an immunological manipulation was capable of mediating the regression of established growing cancers in humans. The identification of the genes encoding cancer antigens and the development of means for effectively immunizing patients against these antigens has opened important new avenues of exploration for the development of effective active and cell-transfer immunotherapies for patients with cancer.

Original languageEnglish (US)
Pages (from-to)462-475
Number of pages14
JournalJournal of Internal Medicine
Volume250
Issue number6
DOIs
StatePublished - 2001

Keywords

  • Antigens
  • Cancer
  • Immunotherapy
  • Interleukin-2
  • Melanoma

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Progress in the development of immunotherapy for the treatment of patients with cancer'. Together they form a unique fingerprint.

Cite this